- Published
- 22 January 2021
- Journal article
Drug supply shortage in Nigeria during COVID-19: efforts and challenges
- Authors
- Source
- Journal of Pharmaceutical Policy and Practice
Abstract
The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of the drug supply is imported creating a huge supply–demand disparity particularly in times like COVID-19. Nigeria is in need of huge quantities of quality-assured health commodities to effectively respond to the pandemic. Significant shortages of other essential medicines and medical products across the country could be imminent. Drug scarcity in Nigeria during the COVID-19 pandemic period is because of several accumulated factors, majorly as a result of global lockdown, decreased manufacturing, unaddressed regulatory affairs, poor access to resources by the population, lack of buffer stocks, security instability, and poor funding of the healthcare system. This situation if left unattended, could cause serious drawbacks to the health of the populace as well as the quality of life of Nigerians amid the COVID-19 Pandemic. Appropriate measures should be directed to ensure ethical processes on drug production, importation, pricing, and distribution to avoid such events during unavoidable scenarios, like the COVID-19 pandemic and other public health emergencies.
Rights
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Cite as
Faiva, E., Hashim, H., Ramadhan, M., Musa, S., Bchara, J., Tuama, Y., Adebisi, Y., Kadhim, M., Essar, M., Ahmad, S. & Lucero-Prisno III, D. 2021, 'Drug supply shortage in Nigeria during COVID-19: efforts and challenges', Journal of Pharmaceutical Policy and Practice, 14, article no: 17. https://doi.org/10.1186/s40545-021-00302-1
Downloadable citations
Download HTML citationHTML Download BIB citationBIB Download RIS citationRISIdentifiers
- Repository URI
- https://eprints.gla.ac.uk/311397/